Relationship between Serum Concentrations and Muscular Expressions of Selenoproteins on Selenium-Supplemented Insulin Resistance Mouse Model

• Published in: Biological & pharmaceutical bulletin 2024/05/21, Vol.47(5), pp.1000-1007
• Main Authors: Ogino, Hirofumi, Murano, Koichi, Okuno, Tomofumi, Ueno, Hitoshi
• Format: Article
• Language: English
• Subjects: Adipose tissue; Animals; Blood Glucose - metabolism; diabetes; Diabetes mellitus; Diet, High-Fat - adverse effects; Dietary Supplements; Disease Models, Animal; Glucose tolerance; Glutathione peroxidase; Glutathione Peroxidase - blood; Glutathione Peroxidase - metabolism; glutathione peroxidase 3; Glutathione Peroxidase GPX1; High fat diet; Insulin - blood; Insulin Resistance; LC-tandem mass spectrometry (LC-MS/MS); Male; Mass spectroscopy; Methionine; Mice; Muscle, Skeletal - drug effects; Muscle, Skeletal - metabolism; Oxidative stress; Selenium; Selenium - administration & dosage; Selenium - blood; Selenomethionine - administration & dosage; Selenomethionine - pharmacology; selenoprotein P; Selenoprotein P - blood; Selenoprotein P - metabolism; Selenoproteins; Selenoproteins - metabolism; Skeletal muscle; Tandem Mass Spectrometry
• ISSN: 0918-6158; 1347-5215
• DOI: 10.1248/bpb.b23-00662

Previously, insulin resistance and hepatic oxidative stress with increased expressions of glutathione peroxidase (GPx) 1 and selenoprotein P (SelP) were induced in NSY mice, a diabetic mouse model, by administrating a high fat diet (HFD) and seleno-L-methionine (SeMet) for 12 weeks. In this study we developed an analysis method for serum selenoproteins using LC-tandem mass spectrometry (LC-MS/MS) and investigated the effects of supplementary selenium on serum concentrations of selenoproteins as well as protein expression in skeletal muscle as a major insulin target tissue under the same experimental condition. The glucose area under the curves for oral glucose tolerance and insulin tolerance tests indicated that the HFD induced insulin resistance, whereas the treatment of SeMet + HFD showed insignificant promotion compared with the HFD-induced insulin resistance. Although the expressions of GPx1 in gastrocnemius and soleus were not significantly induced by supplementary SeMet nor HFD administration, the expressions of SelP in both skeletal muscles were significantly induced by the treatment of SeMet + HFD. There were also significant increases in serum concentrations of SelP by supplementary SeMet + HFD administration, whereas GPx3 was augmented by supplementary SeMet only. These results indicated that the HFD intake under the sufficient selenium status augmented the blood secretion of SelP, which may participate in the reduction of insulin sensitivity in skeletal muscles as well as liver or adipose tissues, and it is a better indicator of deterioration than GPx3 as it is a major selenoprotein in serum.